Literature DB >> 30172296

Bacteria and bacterial products: Foe and friends to Caenorhabditis elegans.

Fazlurrahman Khan1, Saurabh Jain2, Sandra Folarin Oloketuyi2.   

Abstract

Caenorhabditis elegans is a model organism for the study of different molecular, biochemical, microbial and immunity-related mechanisms. In its natural habitat, C. elegans survives by feeding microorganisms (mainly bacteria), though majorly on Escherichia coli OP50 when grown in the laboratory. Numerous bacteria are shown to influence the lifespan, behavioural responses and innate immunity of C. elegans. The secondary metabolites produced by bacteria have shown to play key role in C. elegans longevity. This behaviour provides insights for potential development of new strategies for the treatment of diseases in other species, including humans. This review explains the concept of C. elegans microbiome, different mechanisms employed in its longevity and resistance against bacterial pathogens and the effects of various bacteria (both beneficial and harmful) as well as their products on the life cycle of C. elegans.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Bacteria; C. elegans; Longevity; Metabolites

Mesh:

Year:  2018        PMID: 30172296     DOI: 10.1016/j.micres.2018.06.012

Source DB:  PubMed          Journal:  Microbiol Res        ISSN: 0944-5013            Impact factor:   5.415


  8 in total

1.  Effects of bacterial-feeding nematodes and organic matter on microbial activity and oil degradation in contaminated soil.

Authors:  Jihai Zhou; Rongxia Huang; Shuanghuai Cheng; Jiajie Tang; Houbao Fan
Journal:  Environ Sci Pollut Res Int       Date:  2018-10-23       Impact factor: 4.223

2.  Intra Strain Variation of the Effects of Gram-Negative ESKAPE Pathogens on Intestinal Colonization, Host Viability, and Host Response in the Model Organism Caenorhabditis elegans.

Authors:  Euan Scott; Lindy Holden-Dye; Vincent O'Connor; Matthew E Wand
Journal:  Front Microbiol       Date:  2020-01-21       Impact factor: 5.640

3.  Antimicrobial Biophotonic Treatment of Ampicillin-Resistant Pseudomonas aeruginosa with Hypericin and Ampicillin Cotreatment Followed by Orange Light.

Authors:  Seemi Tasnim Alam; Tram Anh Ngoc Le; Jin-Soo Park; Hak Cheol Kwon; Kyungsu Kang
Journal:  Pharmaceutics       Date:  2019-12-01       Impact factor: 6.321

4.  Pmr-1 gene affects susceptibility of Caenorhabditis elegans to Staphylococcus aureus infection through glycosylation and stress response pathways' alterations.

Authors:  Emily Schifano; Graziella Ficociello; Simone Vespa; Salil Ghosh; John F Cipollo; Claudio Talora; Lavinia Vittoria Lotti; Patrizia Mancini; Daniela Uccelletti
Journal:  Virulence       Date:  2019-12       Impact factor: 5.882

5.  Lipopolysaccharide exposure induces oxidative damage in Caenorhabditis elegans: protective effects of carnosine.

Authors:  Jing Ma; Xiaoyuan Xu; Ranran Wang; Haijing Yan; Huijuan Yao; Hongmei Zhang; Shaowei Jiang; Ajing Xu
Journal:  BMC Pharmacol Toxicol       Date:  2020-12-03       Impact factor: 2.483

Review 6.  Approaches to discern if microbiome associations reflect causation in metabolic and immune disorders.

Authors:  Marijana Basic; Dominique Dardevet; Peter Michael Abuja; Silvia Bolsega; Stéphanie Bornes; Robert Caesar; Francesco Maria Calabrese; Massimo Collino; Maria De Angelis; Philippe Gérard; Miguel Gueimonde; François Leulier; Eva Untersmayr; Evelien Van Rymenant; Paul De Vos; Isabelle Savary-Auzeloux
Journal:  Gut Microbes       Date:  2022 Jan-Dec

7.  Pediococcus acidilactici P25 Protected Caenorhabditis elegans against Enterotoxigenic Escherichia coli K88 Infection and Transcriptomic Analysis of Its Potential Mechanisms.

Authors:  Keqin Tan; Dun Deng; Xianyong Ma; Yiyan Cui; Zhimei Tian
Journal:  Biomed Res Int       Date:  2020-03-30       Impact factor: 3.411

8.  Health and longevity studies in C. elegans: the "healthy worm database" reveals strengths, weaknesses and gaps of test compound-based studies.

Authors:  Nadine Saul; Steffen Möller; Francesca Cirulli; Alessandra Berry; Walter Luyten; Georg Fuellen
Journal:  Biogerontology       Date:  2021-03-08       Impact factor: 4.277

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.